医药政策法规
- (2023-06-20)
- (2023-06-20)
- (2023-06-20)
- (2023-06-20)
- (2023-06-19)
- (2023-06-19)
- (2023-06-19)
- (2023-06-19)
- (2023-06-19)
- (2023-06-19)
- (2023-06-17)
- (2023-06-16)
- (2023-06-16)
- (2023-06-16)
- (2023-06-16)
- (2023-06-16)
- (2023-06-16)
- (2023-06-16)
- (2023-06-16)
- (2023-06-16)
- (2023-06-16)
- (2023-06-15)
- (2023-06-14)
- (2023-06-14)
- (2023-06-14)
- (2023-06-14)
- (2023-06-13)
- (2023-06-13)
- (2023-06-13)
- (2023-06-13)
- (2023-06-13)
- (2023-06-13)
- (2023-06-12)
- (2023-06-12)
- (2023-06-12)
- (2023-06-12)
- (2023-06-12)
- (2023-06-12)
- (2023-06-12)
- (2023-06-12)
- (2023-06-12)
- (2023-06-12)
- (2023-06-09)
Molecular Therapy Nucleic Acids :AAV9介导的miR34a可改善脊髓性肌萎缩小鼠的运动障碍
(2023-06-09)- (2023-06-09)
- (2023-06-09)
- (2023-06-09)
- (2023-06-08)
- (2023-06-08)
- (2023-06-08)
- (2023-06-08)
- (2023-06-08)
- (2023-06-08)
- (2023-06-08)
- (2023-06-07)
- (2023-06-07)
- (2023-06-07)
- (2023-06-07)
- (2023-06-06)
- (2023-06-06)